MoodElite T-4003-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MoodElite T-4003-1, covering 2023-03-22 to 2023-03-22. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention [Phase 1, Phase 2]